Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on April 22, 2026

Apr. 22, 2026

From Quantum Cryptography to AI Data Centers: Public Companies Present at April 23 Virtual Investor Conference

Indeterminate EIN Presswire

Apr. 22, 2026

ShadowDragon and District 4 Labs Announce Strategic Partnership to Transform OSINT and Digital Investigations

Indeterminate EIN Presswire

Apr. 22, 2026

Rehavior Applauds Gateway Rehab’s Telehealth Milestone

Indeterminate EIN Presswire

Apr. 22, 2026

Intellect eMACH.ai Payments Receives Nacha Consulting’s Highest Rating Across All Four Major US Payment Rails

Indeterminate EIN Presswire

Apr. 22, 2026

Tripkicks Launches Catalyst: Intelligence Platform That Creates Self-Improving Corporate Travel Programs

Indeterminate EIN Presswire

Apr. 22, 2026

Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)

Indeterminate GlobeNewswire

Apr. 22, 2026

Elevra Lithium Quarterly Activities Report

Indeterminate GlobeNewswire

Apr. 22, 2026

The Elmet Group Co. Announces Pricing of Upsized Initial Public Offering

Indeterminate GlobeNewswire

Apr. 22, 2026

Prolific Studio Launches New Brand Focused on High-Impact Explainer Video Production

Indeterminate EIN Presswire

Apr. 22, 2026

Bragar Eagel & Squire, P.C. Urges Gemini Space Station (NASDAQ:GEMI) Investors with Large Losses to Contact the Firm Regarding Upcoming Lead Plaintiff Deadline

Indeterminate GlobeNewswire

Apr. 22, 2026

Sportradar Group AG Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Indeterminate GlobeNewswire

Apr. 22, 2026

Gemini Space Station (GEMI) Facing Securities Class Action Following 75% Post-IPO Collapse – Hagens Berman

Indeterminate GlobeNewswire

Apr. 22, 2026

SLNO 13-DAY DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors to Securities Class Action Alleging Hyperphagia Drug Launch Disruptions – Hagens Berman

Indeterminate GlobeNewswire

Apr. 22, 2026

GROCERY OUTLET INVESTOR ALERT: Bragar Eagel & Squire, P.C. Reminds Grocery Outlet Holding Corp. (NASDAQ:GO) Investors that a Class Action Lawsuit Has Been Filed and Encourages Investors to Contact the Firm

Indeterminate GlobeNewswire

Apr. 22, 2026

SIMPLY GOOD FOODS ALERT: Bragar Eagel & Squire, P.C. is Investigating The Simply Good Foods Company on Behalf of Simply Good Foods Stockholders and Encourages Investors to Contact the Firm

Indeterminate GlobeNewswire

Apr. 22, 2026

 nCino Announces Nick Edwards as Managing Director for APAC

Indeterminate GlobeNewswire

Apr. 22, 2026

Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria

Indeterminate GlobeNewswire

Apr. 22, 2026

Communiqué de presse : Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée

Indeterminate GlobeNewswire

Apr. 22, 2026

Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)

Indeterminate GlobeNewswire

Apr. 22, 2026

Oxford Square Capital Corp. Schedules First Quarter 2026 Earnings Release and Conference Call for April 29, 2026

Indeterminate GlobeNewswire